Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a β1-integrin pathway

Hepatology

Volumn 40, Issue 3, 2004, Pages 636-645

  Newsome, Philip N ^a,b   Tsiaoussis, John ^a   Masson, Steven ^a   Buttery, Robert ^b   Livingston, Cameron ^a   Ansell, Ian ^b   Ross, James A ^b   Sethi, Tariq ^b   Hayes, Peter C ^a   Plevris, John N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIBODY TS2 16; BETA1 INTEGRIN; BETA1 INTEGRIN RECEPTOR; COLLAGEN; COLLAGEN TYPE 4; INTEGRIN RECEPTOR; UNCLASSIFIED DRUG; CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL CULTURE; CELL SURVIVAL; CELL TRANSPLANTATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXPLANT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL; LIVER FAILURE; LIVER GRAFT; LIVER INJURY; LIVER SINUSOID; PORTAL VEIN; PRIORITY JOURNAL; SERUM; SIGNAL TRANSDUCTION; BIOSYNTHESIS; BLOOD; CYTOLOGY; PHYSIOLOGY; TRANSPLANTATION; TUMOR CELL LINE;

ANTIGENS, CD29; APOPTOSIS; CASPASE 3; CASPASES; CELL ADHESION; CELL LINE, TUMOR; COLLAGEN TYPE IV; HEPATOCYTES; HUMANS; LIVER FAILURE;

EID: 4544247561     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20359     Document Type: Article

References (49)

1. Lee WM. Acute liver failure. N Engl J Med 1993;329:1862-1872.
2. Newsome PN, Bathgate AJ, Henderson NC, MacGilchrist AJ, Plevris JN, Masterton G, et al. Referral patterns and social deprivation in paracetamol-induced liver injury in Scotland, Lancet 2001;358:1612-1613.
3. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med 1989;321:1092-1099.
4. Lee LA. Advances in hepatocyte transplantation: a myth becomes reality. J Clin Invest 2001;108:367-369.
5. Muraca M, Gerunda G, Neri D, Vilei MT, Granato A, Feltracco P, et al. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 2002;359:317-318.
6. Gupta S, Rajvanshi P, Irani AN, Palestro CJ, Bhargava KK. Integration and proliferation of transplanted cells in hepatic parenchyma following D-galactosamine-induced acute injury in F344 rats. J Pathol 2000;190:203-210.
7. Gupta S, Bhargava KK, Novikoff PM. Mechanisms of cell engraftment during liver repopulation with hepatocyte transplantation. Semin Liver Dis 1999;19:15-26.
8. Rajvanshi P, Kerr A, Bhargava KK, Burk RD, Gupta S. Efficacy and safety of repeated hepatocyte transplantation for significant liver repopulation in rodents. Gastroenterology 1996;111:1092-1102.
9. Gupta S, Rajvanshi P, Sokhi R, Slehria S, Yam A, Kerr A, et al. Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. HEPATOLOGY 1999;29:509-519.
10. Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol 2001;13:555-562.
11. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
12. Hynes R. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-687.
13. Wu C, Keivens VM, O'Toole TE, McDonald JA, Ginsberg MH. Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell 1995;83:715-724.
14. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999;285:1028-1032.
15. Diamond MS, Springer TA. The dynamic regulation of integrin adhesiveness. Curr Biol 1994;4:506-517.
16. Kim LT, Yamada KM. The regulation of expression of integrin receptors. Proc Soc Exp Biol Med 1997;214:123-131.
17. Cho JY, Fox DA, Horejsi V, Sagawa K, Skubitz KM, Katz DR, et al. The functional interactions between CD98, beta1-integrins, and CD 147 in the induction of U937 homotypic aggregation. Blood 2001;98:374-382.
18. Anilkumar T, Ryan CJ, Aslam M, Poulsom R, Alison M. The anti-proliferative effect of plasma from rats with acute fulminant hepatic failure. Scand J Gastroenterol 1997;32:1152-1161.
19. Demetriou AA, Seifter E, Levenson SM. Effect of sera obtained from normal and partially hepatectomized rats and patients on the growth of cells in tissue culture. Surgery 1974;76:779-785.
20. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Takahashi K, Koura M, et al. Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Exp Cell Res 1986;166:139-150.
21. Gove CD, Hughes RD, Williams R. Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure. Br J Exp Pathol 1982;63:547-553.
22. Tada K, Akamatsu K, Ohta Y. Inhibitory activity of the serum from patients with fulminant hepatitis against liver regeneration. Gastroenterol Jpn 1986;21:228-237.
23. Williams R, Hughes RD, Cochrane AM, Ellis WR, Murray-Lyon IM. Studies on plasma cytotoxicity and liver regeneration in fulminant hepatic failure. Ciba Found Symp 1977;55:299-305.
24. Yamada H, Toda G, Yoshiba M, Hashimoto N, Ikeda Y, Mitsui H, et al. Humoral inhibitor of rat hepatocyte DNA synthesis from patients with fulminant liver failure. HEPATOLOGY 1994;19:1133-1140.
25. Shi Q, Gaylor JD, Cousins R, Plevris J, Hayes PC, Grant MH. The effects of serum from patients with acute liver failure on the growth and metabolism of Hep G2 cells. Artif Organs 1998;22:1023-1030.
26. Fujioka H, Kamohara Y, Kawashita Y, Yamaguchi J, Azuma T, Furui J, et al. Is xenogeneic cytotoxicity of plasma from patients with hepatic failure to porcine hepatocytes less than that in healthy human volunteers? Transplant Proc 1997;29:3495-3496.
27. Hughes RD, Cochrane AM, Thomson AD, Murray-Lyon IM, Williams R. The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes. Br J Exp Pathol 1976;57:348-353.
28. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure [Comments]. Gastroenterology 1989;97:439-445.
29. Watchorn TM, Waddell I, Dowidar N, Ross JA. Proteolysis-inducing factor regulates hepatic gene expression via the transcription factors NF(kappa)B and STAT3. FASEB J 2001;15:562-564.
30. Hart SP, Ross JA, Ross K, Haslett C, Dransfield I, Molecular characterization of the surface of apoptotic neutrophils: implications for functional downregulation and recognition by phagocytes. Cell Death Differ 2000;7:493-503.
31. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 1999;5:662-668.
32. Weber C, Alon R, Moser B, Springer TA. Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis. J Cell Biol 1996;134:1063-1073.
33. Torimura T, Ueno T, Kin M, Inuzuka S, Sugawara H, Tamaki S, et al. Coordinated expression of integrin alpha6beta1 and laminin in hepatocellular carcinoma. Hum Pathol 1997;28:1131-1138.
34. Van Eyken P, Sciot R, Desmet VJ. Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. An immunohistochemical study. J Hepatol 1990;11:43-52.
35. Masumoto A, Hemler ME. Mutation of putative divalent cation sites in the alpha 4 subunit of the integrin VLA-4: distinct effects on adhesion to CS1/fibronectin, VCAM-1, and invasin. J Cell Biol 1993;123:245-253.
36. Coppolino MG, Woodside MJ, Demaurex N, Grinstein S, St Arnaud R, Dedhar S. Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion. Nature 1997;386:843-847.
37. Zhang Z, Vuori K, Wang H, Reed JC, Ruoslahti E. Integrin activation by R-ras. Cell 1996;85:61-69.
38. Hotchin NA, Hall A. The assembly of integrin adhesion complexes requires both extracellular matrix and intracellular rho/rac GTPases. J Cell Biol 1995;131(pt 2):1857-1865.
39. Evans CA, Owen-Lynch PJ, Whetton AD, Dive C. Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells. Cancer Res 1993;53:1735-1738.
40. Simizu S, Imoto M, Masuda N, Takada M, Umezawa K. Involvement of hydrogen peroxide production in erbstatin-induced apoptosis in human small cell lung carcinoma cells. Cancer Res 1996;56:4978-4982.
41. Tallett A, Chilvers ER, Hannah S, Dransfield I, Lawson MF, Haslett C, et al. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells. Cancer Res 1996;56:4255-4263.
42. Boudreau N, Sympson CJ, Werb Z, Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995;267:891-893.
43. Kassner PD, Hemler ME. Interchangeable alpha chain cytoplasmic domains play a positive role in control of cell adhesion mediated by VLA-4, a beta 1 integrin. J Exp Med 1993;178:649-660.
44. Arroyo AG, Garcia-Pardo A, Sanchez-Madrid F. A high affinity conformational state on VLA integrin heterodimers induced by an anti-beta 1 chain monoclonal antibody. J Biol Chem 1993;268:9863-9868.
45. Ramirez M, Segovia JC, Benet I, Arbona C, Guenechea G, Blaya C, et al. Ex vivo expansion of umbilical cord blood (UCB) CD34(+) cells alters the expression and function of alpha 4 beta 1 and alpha 5 beta 1 integrins. Br J Haematol 2001;115:213-221.
46. Sullivan SN, Chase RA, Christofides ND, Bloom SR, Williams R. The gut hormone profile of fulminant hepatic failure. Am J Gastroenterol 1981;76:338-341.
47. Begum NA, Mori M, Matsumata T, Takenaka K, Sugimachi K, Barnard GF. Differential display and integrin alpha 6 messenger RNA overexpression in hepatocellular carcinoma. HEPATOLOGY 1995;22:1447-1455.
48. Enosawa S, Miyashita T, Tanaka H, Li X, Suzuki S, Amemiya H, et al. Prolongation of survival of pigs with ischemic liver failure by treatment with a bioartificial liver using glutamine synthetase transfected recombinant HepG2. Transplant Proc 2001;33:1945-1947.
49. Kobayashi N, Noguchi H, Westerman KA, Matsumura T, Watanabe T, Totsugawa T, et al. Efficient Cre/loxP site-specific recombination in a HepG2 human liver cell line. Cell Transplant 2000;9:737-742.